Donald A. Denkhaus - 11 Nov 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Donald A. Denkhaus
Issuer symbol
CPRX
Transactions as of
11 Nov 2022
Net transactions value
-$331,880
Form type
4
Filing time
15 Nov 2022, 16:00:37 UTC
Previous filing
15 Sep 2022
Next filing
08 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale $331,880 -20,000 -6.7% $16.59 277,666 11 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. Denkhaus remains a director of the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold at prices ranging from $16.58 to $16.65 per share.